PEDIATRICS Vol. 23 No. 1 January 1959, pp. 5-7
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SASS-KORTSAK, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SASS-KORTSAK, A.

TREATMENT OF HEPATIC COMA

ANDREW SASS-KORTSAK M.D.1

1 Research Institute, Hospital for Sick Children, 555 University Ave., Toronto, Ontario, Canada

A PECULIAR neurologic syndrome, combined with alteration in consciousness and culminating in coma, is one of the most serious manifestations of liver failure. Better understanding of the fundamental metabolic changes leading to the development of hepatic coma have resulted lately in improved methods of treatment and prevention.

The accumulation of ammonia in the blood and tissues was shown to be at least one of the important factors in the causation of hepatic coma. The ammonia derives from nitrogenous substances of unknown nature which are produced by the normal bacterial flora in the bowel from dietary protein and are absorbed into the portal venous system. An inability of the failing liver to convert ammonia to urea and the presence of natural or artificial shunts between the portal and systemic venous bed, allowing for these substances to bypass the liver, are the two key factors, either one or both of which may result in accumulation of ammonia in the body.